Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00963560 · ClinicalTrials.gov registry record · Phase 4
Presbyopia-Correcting Intraocular Lenses (IOLs)
A Phase 4 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 132
- Enrollment target
NCT00963560 is a Phase 4 study that has completed, run by Alcon Research. The registered enrollment target is 132 participants.
The verdict
NCT00963560, a Phase 4 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 132 participants
- Enrollment target
Study Summary
The purpose of this study is to prospectively evaluate postoperative visual and refractive parameters in a series of subjects bilaterally implanted with Presbyopia-Correcting Intraocular Lenses (IOLs).
Interventions
- DEVICE ReSTOR +3
- DEVICE Crystalens AO
- DEVICE Crystalens HD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2009-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00963560
The ClinicalTrials.gov registry entry for NCT00963560 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which ReSTOR +3 is the first listed.
NCT00963560 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00963560 about?
NCT00963560 is a clinical study titled "Presbyopia-Correcting Intraocular Lenses (IOLs)". The purpose of this study is to prospectively evaluate postoperative visual and refractive parameters in a series of subjects bilaterally implanted with Presbyopia-Correcting Intraocular Lenses (IOLs).
What is the current status of trial NCT00963560?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 132 participants. The study started on 2009-08.
What interventions are being tested in trial NCT00963560?
The interventions under investigation include: ReSTOR +3 (DEVICE), Crystalens AO (DEVICE), Crystalens HD (DEVICE).
Who is sponsoring clinical trial NCT00963560?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.